ARCT
Arcturus Therapeutics Holdings Inc.
Company Overview
| Mkt Cap | $268.29M | Price | $9.97 |
| Volume | 929.55K | Change | +3.53% |
| P/E Ratio | -3.3 | Open | $9.81 |
| Revenue | $152.3M | Prev Close | $9.63 |
| Net Income | $-80.9M | 52W Range | $8.04 - $24.17 |
| Div Yield | N/A | Target | $58.11 |
| Overall | 38 | Value | 60 |
| Quality | 31 | Technical | 25 |
No chart data available
Stock Overview
Updated DailyArcturus Therapeutics Holdings Inc. (ARCT) is a leading Healthcare company in the Biotechnology industry, currently trading at $9.97 with a market capitalization of $268.29 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating concerning quality fundamentals with a MarketXLS quality score of 31.
Today's trading session shows ARCT with a volume of 930K shares. The stock opened up 1.87% from yesterday's close of $9.63. Current analyst estimates project earnings of $-3.49 per share for this year, with next year targeting $-2.75.
ARCT demonstrates concerning technical signals based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including NWBO, NYMX, OHCS, OMIC.
Key investment considerations for ARCT include concerning overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 482.8%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 09:42 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ARCT | $9.97 | +3.5% | 929.55K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Arcturus Therapeutics Holdings Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW